###begin article-title 0
###xml 62 66 <span type="species:ncbi:10116">rats</span>
Reduction in renal ACE2 expression in subtotal nephrectomy in rats is ameliorated with ACE inhibition
###end article-title 0
###begin p 1
###xml 0 1 0 1 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">1</sup>
1These authors contributed equally to the work.
###end p 1
###begin p 2
###xml 614 616 614 616 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 635 637 635 637 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 664 667 664 667 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 841 842 841 842 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 871 872 871 872 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 962 965 962 965 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 987 988 987 988 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1068 1069 1068 1069 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1079 1080 1079 1080 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1176 1177 1176 1177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1195 1196 1195 1196 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1220 1221 1220 1221 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1257 1258 1257 1258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1292 1293 1292 1293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1364 1365 1364 1365 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 1395 1398 1395 1398 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 1420 1421 1420 1421 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 485 489 <span type="species:ncbi:10116">rats</span>
###xml 572 576 <span type="species:ncbi:10116">rats</span>
###xml 739 743 <span type="species:ncbi:10116">rats</span>
###xml 901 905 <span type="species:ncbi:10116">rats</span>
###xml 1123 1127 <span type="species:ncbi:10116">rats</span>
###xml 1137 1141 <span type="species:ncbi:10116">rats</span>
Alterations within the RAS (renin-angiotensin system) are pivotal for the development of renal disease. ACE2 (angiotensin-converting enzyme 2) is expressed in the kidney and converts the vasoconstrictor AngII (angiotensin II) into Ang-(1-7), a peptide with vasodilatory and anti-fibrotic actions. Although the expression of ACE2 in the diabetic kidney has been well studied, little is known about its expression in non-diabetic renal disease. In the present study, we assessed ACE2 in rats with acute kidney injury induced by STNx (subtotal nephrectomy). STNx and Control rats received vehicle or ramipril (1 mg.kg-1 of body weight.day-1), and renal ACE, ACE2 and mas receptor gene and protein expression were measured 10 days later. STNx rats were characterized by polyuria, proteinuria, hypertension and elevated plasma ACE2 activity (all P<0.01) and plasma Ang-(1-7) (P<0.05) compared with Control rats. There was increased cortical ACE binding and medullary mas receptor expression (P<0.05), but reduced cortical and medullary ACE2 activity in the remnant kidney (P<0.05 and P<0.001 respectively) compared with Control rats. In STNx rats, ramipril reduced blood pressure (P<0.01), polyuria (P<0.05) and plasma ACE2 (P<0.01), increased plasma Ang-(1-7) (P<0.001), and inhibited renal ACE (P<0.001). Ramipril increased both cortical and medullary ACE2 activity (P<0.01), but reduced medullary mas receptor expression (P<0.05). In conclusion, our results show that ACE2 activity is reduced in kidney injury and that ACE inhibition produced beneficial effects in association with increased renal ACE2 activity. As ACE2 both degrades AngII and generates the vasodilator Ang-(1-7), a decrease in renal ACE2 activity, as observed in the present study, has the potential to contribute to the progression of kidney disease.
###end p 2
###begin title 3
INTRODUCTION
###end title 3
###begin p 4
###xml 120 121 120 121 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 122 123 122 123 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B2">2</xref>
###xml 166 167 166 167 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B3">3</xref>
###xml 168 169 168 169 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B5">5</xref>
###xml 430 431 430 431 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B6">6</xref>
###xml 432 433 432 433 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B7">7</xref>
###xml 467 470 467 470 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 481 482 481 482 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B8">8</xref>
###xml 644 645 644 645 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 646 648 646 648 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 764 766 764 766 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
Alterations within the RAS (renin-angiotensin system) are pivotal for the development and progression of renal disease [1,2]. ACE2 (angiotensin-converting enzyme 2) [3-5] is a recently discovered monocarboxypeptidase that regulates RAS through degradation of the vasoconstrictor and pro-fibrotic peptide AngII (angiotensin II) into Ang-(1-7) [angiotensin-(1-7)], a peptide reported to have vasodilatory and anti-fibrotic actions [6,7] via actions at the Ang-(1-7) or mas receptor [8]. In normal physiology, ACE2 is highly expressed in the kidney and has been localized to the glomerulus, where it is expressed in podocytes and mesangial cells [9,10], and to the proximal tubules [11]. ACE2 is also expressed in the medulla in collecting ducts and the vasa rectae [12].
###end p 4
###begin p 5
###xml 103 105 103 105 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 106 108 106 108 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 109 111 109 111 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 196 198 196 198 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B15">15</xref>
###xml 199 201 199 201 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B16">16</xref>
###xml 519 521 519 521 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B17">17</xref>
###xml 594 596 594 596 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 597 599 597 599 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 655 656 655 656 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B9">9</xref>
###xml 729 731 729 731 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B18">18</xref>
###xml 904 906 904 906 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B19">19</xref>
###xml 429 433 <span type="species:ncbi:10090">mice</span>
###xml 601 606 <span type="species:ncbi:10090">mouse</span>
###xml 761 765 <span type="species:ncbi:10090">mice</span>
Previous studies have suggested that the expression of ACE2 may be an important determinant of injury [11,13,14], and the therapeutic potential of increased ACE2 activity has now been recognized [15,16]. Certainly, in renal disease, ACE2 may have renoprotective effects, as when ACE2 is deleted or inhibited renal pathology ensues, presumably because of the removal of a degradative pathway for AngII. For example, ACE2-knockout mice develop glomerulosclerosis, which can be prevented by angiotensin receptor blockade [17], and pharmacological inhibition of ACE2 in the spontaneously diabetic (db/db) mouse accelerates albuminuria and glomerulosclerosis [9] and causes glomerular injury in STZ (streptozotocin)-induced diabetes [18]. In addition, ACE2-knockout mice crossed with a model of Type 1 diabetes also had accelerated kidney injury that was ameliorated by an ARB (angiotensin receptor blocker) [19].
###end p 5
###begin p 6
###xml 98 99 98 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B1">1</xref>
###xml 327 329 327 329 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 330 332 330 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 554 556 554 556 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 557 559 557 559 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 853 855 853 855 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
###xml 856 858 856 858 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B22">22</xref>
###xml 562 566 <span type="species:ncbi:10116">rats</span>
As both diabetic and non-diabetic renal disease are associated with an overactive intrarenal RAS [1], we were interested in the potential role of ACE2 in non-diabetic renal disease such as that induced by STNx (subtotal nephrectomy), especially as significant increases in renal ACE and AngII occur after renal mass reduction [20-22]. In this model, nephrons are lost through surgical ablation and the remaining nephrons undergo physiological changes, resulting in hypertrophy and hyperfiltration to compensate for the nephron loss. Early after surgery [22,23], rats develop hypertension, polyuria and proteinuria, whilst, over more prolonged time periods, glomerulosclerosis and tubular atrophy further accelerate nephron loss, and this leads to chronic renal disease associated with a decrease in creatinine clearance and tubulointerstitial fibrosis [20-22].
###end p 6
###begin p 7
###xml 436 439 436 439 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 229 248 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 497 501 <span type="species:ncbi:10116">rats</span>
To characterize further the RAS in the kidney and assess the potential involvement of ACE2 in the pathophysiology that occurs after STNx, we examined gene and protein expression as well as localization of ACE2 in the kidney from Sprague-Dawley rats without or with STNx, and compared this with changes in the related enzyme ACE. In addition, the effect of blocking ACE using the ACEI (ACE inhibitor) ramipril on renal ACE, ACE2 and the mas receptor gene and protein expression in Control and STNx rats was assessed.
###end p 7
###begin p 8
###xml 201 204 201 204 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23a">23a</xref>
Part of this work was presented at the High Blood Pressure Research Council of Australia Annual Scientific meeting, held in Melbourne on 4-5 December 2008, and subsequently published in abstract form [23a].
###end p 8
###begin title 9
MATERIALS AND METHODS
###end title 9
###begin title 10
Experimental protocol
###end title 10
###begin p 11
###xml 279 289 279 289 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">ad libitum</italic>
###xml 345 346 345 346 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 378 379 378 379 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 479 481 479 481 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 884 885 884 885 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 902 903 902 903 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 942 943 942 943 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 960 961 960 961 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 1759 1767 1753 1761 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 224 228 <span type="species:ncbi:10116">Rats</span>
###xml 408 427 <span type="species:ncbi:10116">Sprague-Dawley rats</span>
###xml 494 498 <span type="species:ncbi:10116">rats</span>
###xml 827 831 <span type="species:ncbi:10116">Rats</span>
###xml 1086 1090 <span type="species:ncbi:10116">rats</span>
###xml 1263 1267 <span type="species:ncbi:10116">rats</span>
###xml 1452 1456 <span type="species:ncbi:10116">Rats</span>
Experimental procedures were performed in accordance with the National Health and Medical Research Council of Australia guidelines for animal experimentation, and were approved by the Animal Ethics Committee, Austin Health. Rats were housed in a 12 h/12 h light/dark cycle, with ad libitum food containing 0.4-0.6% NaCl (Norco) and water. STNx (n=21) or sham surgery (Controls; n=21) was performed in female Sprague-Dawley rats (body weight, 200-250 g), as described previously [23]. In brief, rats were anaesthetized by intraperitoneal injection of sodium pentobarbitone (60 mg/kg of body weight; Boehringer Ingelheim) and STNx was performed by right nephrectomy, followed by infarction of approximately two-thirds of the left kidney with selective ligation of all but one of the extrarenal branches of the left renal artery. Rats were randomly allocated to a vehicle-treated group (n=10 for Control; n=9 for STNx) or an ACEI-treated group (n=11 for Control; n=12 for STNx) for 10 days. The ACEI ramipril was administered by daily gavage at a dose of 1 mg/kg of body weight. On day 9, rats were housed in metabolic cages for 24 h to measure water intake and urine output, and to collect samples of urine for biochemical analysis and protein analysis. On day 10, rats were anaesthetized by intraperitoneal injection of sodium pentobarbitone (60 mg/kg of body weight), and SBP [systolic BP (blood pressure)] was measured via carotid artery cannulation. Rats were then killed by a lethal dose of sodium pentobarbitone. The remnant kidney was removed and weighed. A portion of the kidney was fixed in 4% paraformaldehyde and embedded in paraffin for histopathology. The remainder of the kidney was snap-frozen in 2-methylbutane and stored at -80degreesC for the in vitro autoradiographic studies, ACE2 activity assay and RNA extraction.
###end p 11
###begin title 12
Biochemical analysis
###end title 12
###begin p 13
Plasma and urinary urea and creatinine concentrations were measured using an autoanalyser (Beckman Instruments). Urinary protein was determined using the BCA (bicinchoninic acid) method with a commercially available BCA Protein Assay kit (Pierce).
###end p 13
###begin title 14
Plasma Ang-(1-7) RIA
###end title 14
###begin p 15
###xml 130 131 129 130 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 357 359 350 352 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B24">24</xref>
###xml 415 418 408 411 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 400 410 <span type="species:ncbi:10141">guinea-pig</span>
Blood samples for the determination of Ang-(1-7) were collected into tubes containing 20 mul of an inhibitor cocktail [50 mol/l Na2EDTA, 0.2 mol/l N-ethylmaleimide and 1-2 TIU (trypsin inhibitor units)/ml aprotinin made up in saline] per ml of blood. Plasma was snap-frozen and stored at -80degreesC. Ang-(1-7) was measured by RIA, as described previously [24], using an Ang-(1-7) antibody raised in guinea-pig and 125I-Ang-(1-7) (Prosearch). The intra- and inter-assay coefficients of variation for the assay were 4.5 and 10% respectively.
###end p 15
###begin title 16
QRT-PCR (quantitative real-time-PCR)
###end title 16
###begin p 17
###xml 65 66 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 126 127 126 127 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 379 381 379 381 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 382 384 382 384 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 922 925 922 925 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 992 995 992 995 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 1063 1066 1063 1066 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 516 519 <span type="species:ncbi:10116">rat</span>
Kidneys were dissected into cortex and medulla (Control kidneys; n=7/group) or cortex, medulla and scar (STNx remnant kidney; n=9-10/group). Total RNA was isolated from the dissected kidneys using the RNeasy kit method (Qiagen). cDNA was synthesized with a reverse transcriptase reaction using standard techniques (Superscript II kit; Life Technologies) as described previously [11,13]. Primers and probes were designed using the Primer Express software program (PE Applied Biosystems) with the following sequences: rat ACE 5' oligonucleotide primer, 5'-CACCGGCAAGGTCTGCTT-3'; ACE 3' oligonucleotide primer, 5'-CTTGGCATAGTTTCGTGAGGAA-3'; and ACE probe FAM (6-carboxyfluorescin)-5'-CAACAAGACTGCCACCTGCTGGTCC-3'-TAMRA (6-carboxytetramethylrhodamine); ACE2 5' oligonucleotide primer, 5'-GCCAGGAGATGACCGGAAA-3'; ACE2 3' oligonucleotide primer, 5'-CTGAAGTCTCCATGTCCCAGATC-3', and ACE2 probe, FAM-5'-TTGTCTGCCACCCCACA-3'-TAMRA; mas receptor 5' oligonucleotide primer, 5'-CATCTCTCCTCTCGGCTTTGTG-3'; mas receptor 3' oligonucleotide primer, 5'-CCTCATCCGGAAGCAAAGG-3'; and mas receptor probe, FAM-5'-CGGGATCCTCCTCTGG-3'-TAMRA. QRT-PCR was carried out using a multiplex method with VIC (6-carboxyrhodamine)-labelled 18S as the endogenous control. A relative expression method was applied in the present study using the vehicle-treated control group as the calibrator and all groups were compared with the calibrator group, which was given a value of 1.
###end p 17
###begin title 18
Kidney histopathology
###end title 18
###begin p 19
###xml 322 324 322 324 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B20">20</xref>
To assess glomerulosclerosis and tubulointerstitial injury, renal sections were stained with haematoxylin and eosin and examined in a blinded fashion under high power on a light microscope (magnification x400). A total of 30 glomeruli and 20 fields of tubulointerstitial area were graded using a semi-quantitative method [20].
###end p 19
###begin title 20
Renal ACE activity
###end title 20
###begin p 21
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 81 89 80 88 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 135 138 134 137 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125</sup>
###xml 148 149 147 148 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">K</italic>
###xml 149 150 148 149 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">i</sub>
###xml 186 188 185 187 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B25">25</xref>
###xml 232 235 <span type="species:ncbi:10116">rat</span>
###xml 375 379 <span type="species:ncbi:10116">rats</span>
Renal ACE (n=5/group) was assessed on renal sections (20 mum) using quantitative in vitro autoradiography and the specific radioligand 125I-MK351A (Ki=30 pmol/l) as reported previously [25]. Quantification of two sections from each rat was performed using a microcomputer-imaging device (Imaging Research), and results are expressed as a percentage of the binding in control rats.
###end p 21
###begin title 22
QFS (quenched fluorescent substrate) assay of renal and plasma ACE2 activity
###end title 22
###begin p 23
###xml 125 127 125 127 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 128 130 128 130 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B26">26</xref>
###xml 158 160 158 160 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 912 914 900 902 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
We have developed an assay for ACE2 enzymatic activity in tissue and plasma which has been validated using Western blotting [11,26] and immunohistochemistry [13]. To measure renal ACE2 activity, kidneys were dissected into cortex and medulla (Control kidneys) or cortex, medulla and scar (STNx remnant kidney). The tissue was homogenized in ice-cold TBS [Tris-buffered saline; 25 mmol/l Tris/HCl (pH 7.4) and 125 mmol/l NaCl], and the homogenates were pelleted by ultracentrifugation (45000 rev./min at 4degreesC for 1 h in a TLA 100.2 rotor; Beckman). Prior to the ACE2 activity assay, an aliquot of each sample was diluted 10-fold in ACE2 assay buffer [100 mmol/l Tris/HCl (pH 6.5) and 1 mol/l NaCl]. For plasma ACE2 activity, blood collected into heparinized tubes was centrifuged at 4degreesC and assayed using an ACE2-specific QFS [(7-methoxycoumarin-4-yl)-acetyl-Ala-Pro-Lys (2, 4-dintirophenyl); Auspep] [23].
###end p 23
###begin title 24
###xml 23 26 23 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
Expression of ACE2 and mas receptor protein by immunohistochemistry
###end title 24
###begin p 25
###xml 166 168 166 168 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B13">13</xref>
###xml 171 174 171 174 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">Mas</italic>
###xml 238 241 238 241 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 357 358 356 357 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 359 360 358 359 <sub xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">2</sub>
###xml 724 727 717 720 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 121 124 <span type="species:ncbi:10116">rat</span>
###xml 382 386 <span type="species:ncbi:9925">goat</span>
###xml 484 488 <span type="species:ncbi:9925">goat</span>
###xml 494 500 <span type="species:ncbi:9986">rabbit</span>
Immunohistochemical staining for ACE2 (polyclonal antibody T17 diluted 1:100; Santa Cruz Biotechnology) was performed in rat kidney sections as described previously [13]. Mas receptor immunohistochemistry was performed using a polyclonal mas proto-oncogene antibody (diluted 1:5; Novus Biologicals). Sections (4 mum) were rehydrated, blocked with 3% (v/v) H2O2 and 10% (v/v) normal goat serum before incubation with primary antibody at 4degreesC overnight. The secondary antibody was goat anti-rabbit at a dilution of 1:400. Antibody labelling was visualized using an avidin-biotin complex (ABC kit; Vector Laboratories) and DAB (diaminobenzidine) before counterstaining with haematoxylin. The negative control for ACE2 and mas receptor immunostaining was carried out by omission of the primary antibody. Images were acquired on an Olympus BX50 microscope (objective lens, x20/0.50), using a Leica DFC480 camera and Leica IM50Image Manager.
###end p 25
###begin title 26
Statistical analysis
###end title 26
###begin p 27
###xml 72 73 70 71 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">t</italic>
###xml 275 276 273 274 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
Values are shown as means+/-S.E.M. Data were analysed using a Student's t test for comparison between the vehicle- and ramipril-treated Control, vehicle-treated Control and STNx, and between STNx and STNx with ramipril using the GraphPad PRISM program (GraphPad Software). A P value <0.05 was considered statistically significant.
###end p 27
###begin title 28
RESULTS
###end title 28
###begin title 29
STNx model
###end title 29
###begin p 30
###xml 0 7 0 7 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 172 173 172 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 210 211 210 211 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 257 258 257 258 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 348 349 348 349 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 374 375 374 375 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 480 487 480 487 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 145 149 <span type="species:ncbi:10116">rats</span>
###xml 304 308 <span type="species:ncbi:10116">rats</span>
###xml 315 319 <span type="species:ncbi:10116">rats</span>
###xml 636 640 <span type="species:ncbi:10116">rats</span>
Table 1 shows the changes in physiological and biochemical parameters after STNx and the effect of ACE inhibition with ramipril. Following STNx, rats had poor weight gain (P<0.05), and developed increased SBP (P<0.01) and hypertrophy of the remnant kidney (P<0.001) compared with vehicle-treated Control rats. STNx rats had increased urine volume (P<0.001) and proteinuria (P<0.01), with no change in plasma urea, plasma creatinine or creatinine clearance compared with Controls (Table 1). At this early stage of renal injury, there was no evidence of tubulointerstitial fibrosis or glomerulosclerosis in the remnant kidney of the STNx rats (results not shown), although more sophisticated techniques may detect more subtle injury.
###end p 30
###begin title 31
End-organ weight, physiological parameters, and plasma and urine biochemistry
###end title 31
###begin p 32
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 11 12 11 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 25 26 25 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 70 71 65 66 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 90 91 75 76 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 119 120 89 90 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 225 227 195 197 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 246 248 216 218 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 173 177 <span type="species:ncbi:10116">rats</span>
*P<0.05, **P<0.01 and ***P<0.001 compared with control vehicle; daggerP<0.05, daggerdaggerP<0.01 and daggerdaggerdaggerP<0.001 compared with the appropriate vehicle-treated rats. Ramipril was administered at a dose of 1 mg.kg-1 of body weight.day-1.
###end p 32
###begin p 33
###xml 44 45 44 45 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 92 99 92 99 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 176 177 176 177 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 224 225 224 225 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 478 480 478 480 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B27">27</xref>
###xml 38 42 <span type="species:ncbi:10116">rats</span>
###xml 170 174 <span type="species:ncbi:10116">rats</span>
###xml 218 222 <span type="species:ncbi:10116">rats</span>
###xml 251 255 <span type="species:ncbi:10116">rats</span>
###xml 307 311 <span type="species:ncbi:10116">rats</span>
###xml 350 354 <span type="species:ncbi:10116">rats</span>
Ramipril improved weight gain in STNx rats (P<0.05), but did not affect kidney hypertrophy (Table 1). ACE inhibition significantly decreased SBP in both Control and STNx rats (P<0.01), and reduced urine volume in STNx rats (P<0.05) but not in Control rats. Ramipril had no effect on proteinuria in the STNx rats and caused proteinuria in the Control rats. This effect of ACE inhibition can also occur clinically early after commencing treatment, but does not persist long-term [27].
###end p 33
###begin p 34
###xml 58 59 58 59 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 69 70 69 70 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 90 97 90 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 205 206 205 206 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 365 366 365 366 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 376 377 376 377 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 398 405 398 405 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T1">Table 1</xref>
###xml 121 125 <span type="species:ncbi:10116">rats</span>
###xml 199 203 <span type="species:ncbi:10116">rats</span>
###xml 264 268 <span type="species:ncbi:10116">rats</span>
###xml 359 363 <span type="species:ncbi:10116">rats</span>
STNx increased plasma ACE2 activity and plasma Ang-(1-7) (P<0.01 and P<0.05 respectively; Table 1) compared with Control rats. Ramipril was associated with a decrease in plasma ACE2 activity in STNx rats (P<0.01), but plasma ACE2 activity was unchanged in Control rats. Ramipril treatment significantly increased plasma Ang-(1-7) in both the Control and STNx rats (P<0.01 and P<0.001 respectively; Table 1).
###end p 34
###begin title 35
ACE and ACE2 mRNA expression
###end title 35
###begin p 36
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 234 243 234 243 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 249 250 249 250 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 323 332 323 332 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figures 1</xref>
###xml 338 339 338 339 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">1</xref>
###xml 122 126 <span type="species:ncbi:10116">rats</span>
Figure 1 shows the relative quantification of renal ACE and ACE2 mRNA in the renal cortex and medulla in Control and STNx rats. In the remnant kidney after STNx, there was a reduction in ACE mRNA expression in the cortex and medulla (Figures 1A and 1C) and a decrease in ACE2 mRNA expression in the cortex but not medulla (Figures 1B and 1D) compared with Control kidneys.
###end p 36
###begin title 37
###xml 121 125 <span type="species:ncbi:10116">rats</span>
Relative quantification of cortical (A and B) and medullary (C and D) ACE and ACE2 mRNA using QRT-PCR in control or STNx rats with vehicle or ramipril treatment
###end title 37
###begin p 38
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 31 32 31 32 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
*P<0.05 compared with Control (n=7-10/group).
###end p 38
###begin p 39
###xml 89 97 89 97 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F1">Figure 1</xref>
###xml 173 180 173 180 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
Ramipril had no effect on ACE or ACE2 mRNA expression in either STNx or Control kidneys (Figure 1). No significant changes in ACE or ACE2 mRNA in scar tissue were observed (Table 2).
###end p 39
###begin title 40
###xml 14 17 14 17 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
ACE, ACE2 and mas receptor mRNA and ACE2 activity in scar tissue of the remnant kidney
###end title 40
###begin p 41
###xml 46 48 46 48 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
###xml 67 69 67 69 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">&#8722;1</sup>
Ramipril was administered at a dose of 1 mg.kg-1 of body weight.day-1.
###end p 41
###begin title 42
Renal ACE and ACE2 protein
###end title 42
###begin p 43
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 18 26 18 26 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">in vitro</italic>
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B28">28</xref>
###xml 340 341 340 341 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 410 411 410 411 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 419 427 419 427 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F2">Figure 2</xref>
###xml 404 408 <span type="species:ncbi:10116">rats</span>
Figure 2 shows an in vitro autoradiograph of ACE radiolabelling in Control kidneys and STNx remnant kidneys. In normal kidneys, ACE was localized to the proximal tubules in the inner cortex, as reported previously [28], with lower ACE binding detectable in the medulla. After STNx, ACE activity increased significantly in the inner cortex (P<0.001). Ramipril reduced ACE binding in both Control and STNx rats (P<0.001; Figure 2B).
###end p 43
###begin title 44
###xml 61 64 <span type="species:ncbi:10116">rat</span>
###xml 91 95 <span type="species:ncbi:10116">rats</span>
Localization and quantification of ACE radiolabelling in the rat kidney in Control or STNx rats with vehicle or ramipril treatment
###end title 44
###begin p 45
###xml 4 12 4 12 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">In vitro</italic>
###xml 621 622 621 622 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 659 662 659 662 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">###</sup>
###xml 662 663 662 663 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 718 719 718 719 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 62 65 <span type="species:ncbi:10116">rat</span>
###xml 220 223 <span type="species:ncbi:10116">rat</span>
###xml 556 559 <span type="species:ncbi:10116">rat</span>
###xml 612 616 <span type="species:ncbi:10116">rats</span>
###xml 712 716 <span type="species:ncbi:10116">rats</span>
(A) In vitro autoradiograph showing ACE radiolabelling in the rat kidney. The white colour denotes the highest density of labelling, whereas the black colour represents background labelling. Sections from Control (Sham) rat kidney and STNx kidney without and with ramipril treatment are shown. In the Control kidney, there is abundant ACE radiolabelling of the inner cortex and outer stripe of the outer medulla. STNx increases ACE radiolabelling, which was reduced by ramipril. (B) Relative quantification of ACE radiolabelling in the inner cortex of the rat kidney expressed as a percentage of that in Control rats. ***P<0.001 compared with Control vehicle ###P<0.001 compared with appropriate vehicle-treated rats (n=5/group).
###end p 45
###begin p 46
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
###xml 227 228 227 228 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 248 249 248 249 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 301 310 301 310 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figures 3</xref>
###xml 316 317 316 317 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">3</xref>
###xml 496 497 496 497 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 585 592 585 592 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 295 299 <span type="species:ncbi:10116">rats</span>
###xml 378 382 <span type="species:ncbi:10116">rats</span>
Figure 3 shows ACE2 activity measured in kidney homogenates. In Control kidney, ACE2 activity was detectable in both the renal cortex and medulla. Interestingly, after STNx, ACE2 activity significantly decreased in the cortex (P<0.05) and medulla (P<0.001) compared with vehicle-treated Control rats (Figures 3A and 3B). Ramipril had no effect on renal ACE2 activity in Control rats, but was associated with a significant increase in ACE2 activity in both the cortex and medulla of STNx kidneys (P<0.01). No significant changes in ACE2 activity were observed in the renal scar tissue (Table 2).
###end p 46
###begin title 47
###xml 51 54 <span type="species:ncbi:10116">rat</span>
###xml 81 85 <span type="species:ncbi:10116">rats</span>
ACE2 activity in the cortex (A) and medulla (B) of rat kidney in Control or STNx rats with vehicle or ramipril treatment
###end title 47
###begin p 48
###xml 1 2 1 2 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 15 16 15 16 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 53 55 53 55 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">##</sup>
###xml 55 56 55 56 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 90 91 90 91 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
*P<0.05 and ***P<0.001 compared with Control vehicle ##P<0.01 compared with STNx vehicle (n=7-10/group).
###end p 48
###begin title 49
Localization of ACE2 protein in the renal cortex and medulla
###end title 49
###begin p 50
###xml 176 184 176 184 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 449 457 449 457 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figure 4</xref>
###xml 475 488 475 488 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4A&#8211;4D</xref>
###xml 505 518 505 518 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F4">Figures 4F&#8211;4I</xref>
###xml 764 772 764 772 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F3">Figure 3</xref>
The renal cortex comprises both glomeruli and tubules, although the glomeruli comprise only approx. 5% of the cortex; the medulla includes collecting ducts and the vasa recta. Figure 4 shows the qualitative immunohistochemical localization of ACE2 in the kidney. ACE2 protein was present in the cortex, predominantly, but not exclusively, localized to proximal and distal tubules, and, in the medulla, ACE2 mainly localized to the collecting ducts (Figure 4). Both cortical (Figures 4A-4D) and medullary (Figures 4F-4I) ACE2 immunostaining decreased after STNx, and were qualitatively increased by ramipril treatment. The changes in staining intensity observed with ACE2 immunohistochemistry were consistent with the measurement of renal ACE2 activity as shown in Figure 3.
###end p 50
###begin title 51
###xml 97 100 <span type="species:ncbi:10116">rat</span>
###xml 158 162 <span type="species:ncbi:10116">rats</span>
Light microscopic micrographs showing ACE2 immunohistochemical labelling (brown staining) of the rat kidney cortex (A-E) and medulla (F-J) in Control or STNx rats with vehicle or ramipril treatment
###end title 51
###begin p 52
Micrographs show staining of the tubules in the cortex from vehicle- and ramipril-treated Control (A and B), STNx (C) and ramipril-treated STNx (D) kidneys. Medullary collecting ducts (CD) also stain ACE2 in vehicle- and ramipril-treated Control (F and G), STNx (H) and ramipril-treated STNx (I) kidneys. Immunohistochemical negative (-ve) controls are shown in (E) and (J). DT, distal tubule; Gl, glomeruli; PT, proximal tubules.
###end p 52
###begin title 53
###xml 0 3 0 3 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
mas receptor mRNA expression and localization in the renal cortex and medulla
###end title 53
###begin p 54
###xml 0 8 0 8 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 60 63 60 63 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 170 173 170 173 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 231 232 231 232 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 319 322 319 322 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 344 345 344 345 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 400 407 400 407 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="table" rid="T2">Table 2</xref>
###xml 130 134 <span type="species:ncbi:10116">rats</span>
Figure 5 (upper panel) shows the relative quantification of mas receptor mRNA in the renal cortex and medulla of Control and STNx rats. In the remnant kidney after STNx, mas receptor mRNA expression increased in the renal medulla (P<0.05), but not in the cortex compared with Control. Ramipril led to reduced medullary mas receptor expression (P<0.05) with no changes in renal cortex or scar tissue (Table 2).
###end p 54
###begin title 55
###xml 39 42 39 42 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 97 101 <span type="species:ncbi:10116">rats</span>
Quantification and localization of the mas receptor in the cortex and medulla in Control or STNx rats with vehicle or ramipril treatment
###end title 55
###begin p 56
###xml 72 75 72 75 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 165 166 165 166 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 195 196 195 196 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">#</sup>
###xml 196 197 196 197 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">P</italic>
###xml 223 224 223 224 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">n</italic>
###xml 290 293 290 293 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 682 685 682 685 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 123 127 <span type="species:ncbi:10116">rats</span>
###xml 357 360 <span type="species:ncbi:10116">rat</span>
Upper panels, relative quantification of cortical (A) and medullary (B) mas receptor mRNA using QRT-PCR in Control or STNx rats with vehicle or ramipril treatment. *P<0.05 compared with Control; #P<0.05 compared with STNx (n=7-10/group). Lower panels, light microscopic micrographs showing mas receptor immunohistochemical labelling (brown staining) in the rat kidney cortex (A-E) and medulla (F-J). Micrographs show staining of apical and basal membranes of distal tubules (DT) from Control (A), ramipril-treated Control (B), STNx (C) and ramipril-treated STNx (D) kidneys. Collecting ducts (CD), medullary thin limbs of Henle (TL) and cells between the tubules also stain for the mas receptor in Control (F), ramipril-treated Control (G), STNx (H) and ramipril-treated STNx (I) kidney medulla. Gl, glomeruli; PT, proximal tubules. Immunohistochemical negative (-ve) controls are shown in (E) and (J).
###end p 56
###begin p 57
###xml 40 48 40 48 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 64 67 64 67 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 179 192 179 192 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figures 5A&#8211;5D</xref>
###xml 205 208 205 208 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 363 371 363 371 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">Figure 5</xref>
###xml 373 374 373 374 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="fig" rid="F5">5</xref>
###xml 468 471 468 471 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
Using qualitative immunohistochemistry (Figure 5, lower panel), mas receptor protein was localized predominantly to the basal and apical surfaces of distal tubules in the cortex (Figures 5A-5D). Medullary mas receptor protein was localized to the thin limb of Henle and to cells between the tubules and capillaries, likely to be renomedullary interstitial cells (Figure 5F-5I), although further studies are needed to confirm this. There were no qualitative changes in mas receptor protein expression in the STNx or ramipril-treated animals.
###end p 57
###begin title 58
DISCUSSION
###end title 58
###begin p 59
###xml 862 865 862 865 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 1021 1023 1021 1023 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B29">29</xref>
###xml 329 333 <span type="species:ncbi:10116">rats</span>
###xml 884 889 <span type="species:ncbi:10090">mouse</span>
The major findings of the present study are that an acute reduction in renal mass by STNx increases circulating levels of the enzyme ACE2 and leads to a 50% decrease in renal ACE2 enzymatic activity, which is accompanied by a significant increase in renal ACE activity of the same order. After administration of ramipril to STNx rats, the renal expression of ACE changed in the opposite direction to ACE2, so that as ACE decreased ACE2 activity was enhanced. Our results are consistent with the notion that ACE2 may be playing a protective role in the diseased kidney. As ACE2 both degrades AngII and generates the vasodilator and anti-fibrotic peptide Ang-(1-7), a decrease in renal ACE2 activity, as observed in the present study, has the potential to contribute to the progression of renal injury. Support for this hypothesis comes from a recent study in the mas receptor-knockout mouse, where a lack of Ang-(1-7) action at the renal level caused hyperfiltration, proteinuria and a tendency toward glomerulosclerosis [29].
###end p 59
###begin p 60
###xml 670 672 670 672 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 673 675 673 675 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B31">31</xref>
###xml 144 148 <span type="species:ncbi:10116">rats</span>
###xml 243 247 <span type="species:ncbi:10116">rats</span>
###xml 790 794 <span type="species:ncbi:10116">rats</span>
At this early stage (10 days post-STNx), there was no evidence of glomerular or tubulointerstitial fibrosis or a decline in renal function, but rats were hypertensive with polyuria and proteinuria. Ramipril lowered BP in both Control and STNx rats and increased circulating levels of Ang-(1-7) approx. 80-fold, which may contribute to the antihypertensive effects observed. The elevated levels of plasma Ang-(1-7) observed following ACE inhibition are due to the fact that ACE is responsible for the breakdown of Ang-(1-7), and the results are consistent with findings from others studies that also report significant increases in plasma Ang-(1-7) after ACE inhibition [30,31]. Ramipril not only reduced BP, but also led to a significant decrease in urine volume in STNx but not in Control rats. Interestingly, it was only after STNx that changes in renal ACE2 activity with ramipril were observed.
###end p 60
###begin p 61
###xml 215 217 215 217 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 526 528 526 528 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 876 878 876 878 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 879 881 879 881 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 909 911 909 911 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 912 914 912 914 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 210 213 <span type="species:ncbi:10116">rat</span>
###xml 869 874 <span type="species:ncbi:10090">mouse</span>
###xml 903 907 <span type="species:ncbi:10090">mice</span>
To date the effects of RAS blockade on ACE2 gene expression in the kidney have not been well studied, but the results of the present study are in agreement with our previous work in STZ-induced diabetes in the rat [11]. In that study, renal pathology was associated with low renal tubular ACE2 protein expression, and ACE inhibition improved pathology in association with the restoration of renal ACE2 levels; however, the changes in renal ACE2 protein measured by Western blotting were not reflected by changes in ACE2 mRNA [11]. In the present study, ACE2 protein was measured using a specific ACE2 catalytic activity assay as well as immunostaining, and again no correlation between renal ACE2 activity and ACE2 gene expression was found. Discrepancies between ACE2 mRNA and protein/activity in the renal cortex have also been reported in the spontaneously diabetic mouse (db/db) and in STZ diabetic mice [32,33].
###end p 61
###begin p 62
###xml 230 232 230 232 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B10">10</xref>
###xml 361 363 361 363 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B30">30</xref>
###xml 131 135 <span type="species:ncbi:10090">mice</span>
###xml 355 359 <span type="species:ncbi:10116">rats</span>
The relative effects of RAS blockade on ACE2 expression are also inconsistent. One group reports that, in the renal vasculature of mice, both ACE2 mRNA and protein expression increased after administration of the ARB telmisartan [10], but others have shown no effect of ACE inhibition or angiotensin receptor blockade on ACE2 mRNA in the kidney of normal rats [30]. The results suggest that the regulation of ACE2 may vary according to cell type, as well as the disease and the prevailing BP. It also appears that, in some circumstances, ACE2 is altered at a post-transcriptional level. Taken together, the findings highlight the need for studies to assess not only ACE2 mRNA, but also ACE2 activity/protein.
###end p 62
###begin p 63
###xml 416 418 416 418 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 419 421 419 421 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B33">33</xref>
###xml 490 492 490 492 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B11">11</xref>
###xml 547 549 547 549 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B12">12</xref>
###xml 800 802 800 802 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B34">34</xref>
###xml 803 805 803 805 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B36">36</xref>
A strength of the present study was the examination of the expression of ACE2 at the gene and protein level in both the cortex and medulla of the kidney. The cortex comprises both glomeruli and proximal tubules, but, as the glomeruli make up only 5% of cortical mass, changes in cortical ACE2 reflect changes occurring in the proximal tubule. In general, most groups use the cortex for RNA and protein preparations [32,33] or have sieved the preparations to separate glomeruli and tubules [11]. However, ACE2 is also present in the renal medulla [12], which is a structure that plays an important role in maintaining body fluid and electrolyte balance, and BP homoeostasis through the actions of vasoactive hormones to influence medullary/papillary blood flow and urinary water and sodium excretion [34-36].
###end p 63
###begin p 64
###xml 275 278 275 278 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 289 291 289 291 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B37">37</xref>
###xml 351 353 351 353 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B38">38</xref>
###xml 354 356 354 356 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B39">39</xref>
###xml 428 430 428 430 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B40">40</xref>
###xml 515 517 515 517 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B41">41</xref>
###xml 858 861 858 861 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 1022 1025 1022 1025 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 457 461 <span type="species:ncbi:10116">rats</span>
###xml 609 613 <span type="species:ncbi:10116">rats</span>
The regulation of ACE2 in the medulla in renal disease has not been assessed previously. We found that ACE2 was localized to the medullary collecting ducts, where its role to generate Ang-(1-7) may in turn regulate water transport through an interaction with the Ang(1-7) or mas receptor [37]. It is known that Ang-(1-7) exerts anti-diuretic effects [38,39], and Ang-(1-7) receptor blockade results in diuresis and natriuresis [40]. Moreover, in transgenic rats overexpressing Ang-(1-7), urinary flow is decreased [41]. As mentioned above, we have observed a reduction in ACE2 activity in the medulla in STNx rats, which also had polyuria. Although we were not able to measure renal Ang-(1-7) peptide levels, the reduction in medullary ACE2 might be expected to decrease renal Ang-(1-7) and increase urine flow. The finding of an increased expression of the mas receptor in the renal medulla in STNx would be consistent with this speculation, as would the observation that restoration of renal medullary ACE2 activity and mas receptor expression following ACE inhibition reduced urine volume.
###end p 64
###begin p 65
###xml 225 227 225 227 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 323 325 323 325 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 326 328 326 328 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">db</italic>
###xml 404 406 404 406 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B32">32</xref>
###xml 965 968 965 968 <italic xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">mas</italic>
###xml 329 334 <span type="species:ncbi:10090">mouse</span>
###xml 604 608 <span type="species:ncbi:10116">rats</span>
###xml 678 682 <span type="species:ncbi:10116">rats</span>
###xml 764 768 <span type="species:ncbi:10116">rats</span>
Our results also highlight that tissue-specific changes in ACE2 occur in renal disease. The reduction in renal ACE2 activity in STNx contrasts with our previous work that demonstrated increased cardiac ACE2 activity in STNx [23]. Other investigators have observed a similar discordance in other experimental models; in the db/db mouse, ACE2 activity was increased in the kidney cortex but not the heart [32]. It is likely that the expression of ACE2 may be specific for each model as well as each organ, and importantly may be dependent on the time point studied. In this model of renal injury, the STNx rats had polyuria and proteinuria, but at this early hyperfiltering stage rats were able to maintain normal creatinine clearance. In long-term studies in STNx, rats develop worsening renal function as well as histological changes in glomerulosclerosis and tubulointerstitial fibrosis. Future studies should investigate whether the renal changes in ACE2 and the mas receptor observed 10 days after renal injury are maintained over the long-term and, indeed, contribute to the development of complications and the progression of disease.
###end p 65
###begin p 66
###xml 275 277 275 277 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 368 370 368 370 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
###xml 722 724 722 724 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B42">42</xref>
###xml 928 930 928 930 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B23">23</xref>
The present study also highlights the problem of interpreting plasma ACE2 levels in the context of changes in ACE2 at the tissue level. The major contribution to plasma ACE2 levels is from shedding of the enzyme from the major sites of ACE2 expression, the heart and kidney [42]. We have shown previously that both plasma and cardiac ACE2 are elevated following STNx [23] and, in the present study, we report increased plasma ACE2 activity in the context of decreased renal ACE2. Taken together, our results suggests that circulating ACE2 levels are indicative of cardiac rather than renal ACE2 levels in STNx. Support for this comes from the results of the ACEI treatment arm; as ACE2 activity is not inhibited by ACEIs [42], any change in plasma ACE2 activity is likely to reflect changes at the tissue level. The finding that ramipril treatment was associated with a reduction in both plasma and cardiac ACE2 levels in STNx [23], but an increase in renal ACE2 activity, would support this.
###end p 66
###begin p 67
###xml 396 398 396 398 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B43">43</xref>
###xml 660 662 660 662 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B14">14</xref>
###xml 680 682 680 682 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B44">44</xref>
###xml 1127 1129 1127 1129 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B45">45</xref>
###xml 202 207 <span type="species:ncbi:9606">human</span>
###xml 388 394 <span type="species:ncbi:9606">humans</span>
###xml 562 570 <span type="species:ncbi:9606">patients</span>
###xml 783 791 <span type="species:ncbi:9606">patients</span>
###xml 1048 1056 <span type="species:ncbi:9606">patients</span>
It is currently unclear how the perturbations in tissue and circulating levels of ACE2 observed in an animal model of renal disease relate to the clinical setting. Several studies have assessed ACE2 in human renal disease, with inconsistent results. One study has shown that ACE2 immunostaining was increased in the glomeruli and peritubular capillaries in a variety of renal diseases in humans [43]. More recently, however, a significant decrease in ACE2 gene and protein expression, and an increase in ACE mRNA, were reported in cortical tubules from diabetic patients, but not in those with either focal glomerulosclerosis or chronic allograft nephropathy [14]. Mizuri et al. [44] also showed decreased ACE2 and increased ACE expression in the tubulointerstitium and glomeruli of patients with overt diabetic nephropathy. Although these results may suggest that only diabetic kidney disease is associated with a reduction in ACE2 gene and protein expression, other investigators have found that ACE2 expression is similar in renal biopsies from patients with diabetes, primary glomerular disease, nephrosclerosis and lupus [45].
###end p 67
###begin p 68
###xml 755 757 755 757 <xref xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" ref-type="bibr" rid="B46">46</xref>
In conclusion, the emerging evidence suggests that the carboxypeptidase ACE2 serves as a negative regulator of RAS and acts to counterbalance the actions of ACE by regulating tissue AngII levels. As the injury in renal disease is modulated, in part, by enhanced ACE activity leading to increased AngII levels, a reduction in renal ACE2 activity and, hence, the loss of a pathway for AngII peptide degradation may contribute to the progression of renal injury. The lack of generation of a potentially renoprotective peptide, Ang-(1-7), may also contribute to ongoing renal damage. Strategies that amplify renal ACE2 expression or synthesis may be a useful therapeutic option in kidney disease, and the recent description of small-molecule ACE2 activators [46] will allow this approach to be tested, at least in experimental models.
###end p 68
###begin title 69
FUNDING
###end title 69
###begin p 70
###xml 31 74 31 74 <funding-source xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML" id="gs1">Austin Hospital Medical Research Foundation</funding-source>
This work was supported by the Austin Hospital Medical Research Foundation.
###end p 70
###begin article-title 71
###xml 40 48 <span type="species:ncbi:9606">patients</span>
Optimizing treatment of hypertension in patients with diabetes
###end article-title 71
###begin article-title 72
The importance of the intrarenal renin-angiotensin system
###end article-title 72
###begin article-title 73
A novel angiotensin-converting enzyme-related carboxypeptidase (ACE2) converts angiotensin I to angiotensin 1-9
###end article-title 73
###begin article-title 74
###xml 2 7 <span type="species:ncbi:9606">human</span>
A human homolog of angiotensin-converting enzyme: cloning and functional expression as a captopril-insensitive carboxypeptidase
###end article-title 74
###begin article-title 75
ACE2, a new regulator of the renin-angiotensin system
###end article-title 75
###begin article-title 76
Angiotensin-converting enzyme 2 and angiotensin-(1-7): an evolving story in cardiovascular regulation
###end article-title 76
###begin article-title 77
Molecular mechanisms of inhibition of vascular growth by angiotensin-(1-7)
###end article-title 77
###begin article-title 78
Angiotensin-(1-7) is an endogenous ligand for the G protein-coupled receptor Mas
###end article-title 78
###begin article-title 79
Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin-converting enzyme: implications for albuminuria in diabetes
###end article-title 79
###begin article-title 80
Localization of ACE2 in the renal vasculature: amplification by angiotensin II type 1 receptor blockade using telmisartan
###end article-title 80
###begin article-title 81
Characterization of renal angiotensin-converting enzyme 2 in diabetic nephropathy
###end article-title 81
###begin article-title 82
###xml 84 87 <span type="species:ncbi:10116">rat</span>
The role of angiotensin converting enzyme 2 in the generation of angiotensin 1-7 by rat proximal tubules
###end article-title 82
###begin article-title 83
###xml 51 54 <span type="species:ncbi:10116">rat</span>
###xml 59 65 <span type="species:ncbi:9606">humans</span>
Myocardial infarction increases ACE2 expression in rat and humans
###end article-title 83
###begin article-title 84
###xml 55 63 <span type="species:ncbi:9606">patients</span>
Decreased glomerular and tubular expression of ACE2 in patients with type 2 diabetes and kidney disease
###end article-title 84
###begin article-title 85
ACE2 and diabetic complications
###end article-title 85
###begin article-title 86
New aspects of the renin-angiotensin system: angiotensin-converting enzyme 2: a potential target for treatment of hypertension and diabetic nephropathy
###end article-title 86
###begin article-title 87
Loss of angiotensin-converting enzyme-2 leads to the late development of angiotensin II-dependent glomerulosclerosis
###end article-title 87
###begin article-title 88
###xml 122 126 <span type="species:ncbi:10090">mice</span>
ACE2 inhibition worsens glomerular injury in association with increased ACE expression in streptozotocin-induced diabetic mice
###end article-title 88
###begin article-title 89
Loss of angiotensin converting enzyme-2 (ACE2) accelerates diabetic kidney injury
###end article-title 89
###begin article-title 90
###xml 95 99 <span type="species:ncbi:10116">rats</span>
Vasopeptidase inhibition attenuates the progression of renal injury in subtotal nephrectomised rats
###end article-title 90
###begin article-title 91
Role of angiotensin II in tubulointerstitial injury
###end article-title 91
###begin article-title 92
Adaptation to nephron loss. 2008
###end article-title 92
###begin article-title 93
###xml 27 30 <span type="species:ncbi:10116">rat</span>
Acute kidney injury in the rat causes cardiac remodelling and increases ACE2 expression
###end article-title 93
###begin article-title 94
###xml 117 120 <span type="species:ncbi:10116">rat</span>
Role for renal angiotensin converting enzyme 2 in the adaption to nephron loss following subtotal nephrectomy in the rat
###end article-title 94
###begin article-title 95
Upregulation of hepatic angiotensinconverting enzyme 2 (ACE2) and angiotensin-(1-7) levels in experimental biliary fibrosis
###end article-title 95
###begin article-title 96
Reversal of cardiac hypertrophy and fibrosis by S21402, a dual inhibitor of neutral endopeptidase and angiotensin converting enzyme in SHRs
###end article-title 96
###begin article-title 97
###xml 54 59 <span type="species:ncbi:9606">human</span>
Angiotensin-converting enzyme 2 catalytic activity in human plasma is masked by an endogenous inhibitor
###end article-title 97
###begin article-title 98
Proteinuria during long-term captopril therapy
###end article-title 98
###begin article-title 99
###xml 114 118 114 118 <sup xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:mml="http://www.w3.org/1998/Math/MathML">125I</sup>
###xml 49 52 <span type="species:ncbi:10116">rat</span>
Localization of angiotensin converting enzyme in rat forebrain and other tissues by invitro autoradiography using 125I-labelled MK351A
###end article-title 99
###begin article-title 100
Genetic deletion of the angiotensin-(1-7) receptor Mas leads to glomerular hyperfiltration and microalbuminuria
###end article-title 100
###begin article-title 101
Effects of renin-angiotensin system blockade on renal angiotensin-(1-7) forming enzymes and receptors
###end article-title 101
###begin article-title 102
Converting enzyme determines plasma clearance of angiotensin-(1-7)
###end article-title 102
###begin article-title 103
###xml 34 38 <span type="species:ncbi:10090">mice</span>
ACE and ACE2 activity in diabetic mice
###end article-title 103
###begin article-title 104
###xml 73 77 <span type="species:ncbi:10090">mice</span>
Increased ACE 2 and decreased ACE protein in renal tubules from diabetic mice: a renoproptective combination?
###end article-title 104
###begin article-title 105
Paracrine regulation of the renal microcirculation
###end article-title 105
###begin article-title 106
The renal medulla and hypertension
###end article-title 106
###begin article-title 107
Renal medullary circulation: hormonal control
###end article-title 107
###begin article-title 108
###xml 48 51 <span type="species:ncbi:10116">rat</span>
Angiotensin-(1-7) stimulates water transport in rat inner medullary collecting duct: evidence for involvement of vasopressin V2 receptors
###end article-title 108
###begin article-title 109
###xml 54 58 <span type="species:ncbi:10116">rats</span>
Angiotensin-(1-7) is a potent antidiuretic peptide in rats
###end article-title 109
###begin article-title 110
Evidence for a physiological role of angiotensin-(1-7) in the control of hydroelectrolyte balance
###end article-title 110
###begin article-title 111
###xml 139 143 <span type="species:ncbi:10116">rats</span>
Diuresis and natriuresis produced by long term administration of a selective Angiotensin-(1-7) antagonist in normotensive and hypertensive rats
###end article-title 111
###begin article-title 112
###xml 29 33 <span type="species:ncbi:10116">rats</span>
Renal function in transgenic rats expressing an angiotensin(1-7)-producing fusion protein
###end article-title 112
###begin article-title 113
Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism
###end article-title 113
###begin article-title 114
###xml 25 30 <span type="species:ncbi:9606">human</span>
Renal ACE2 expression in human kidney disease
###end article-title 114
###begin article-title 115
Expression of ACE and ACE2 in individuals with diabetic kidney disease and healthy controls
###end article-title 115
###begin article-title 116
###xml 54 59 <span type="species:ncbi:9606">human</span>
Tissue gene expression of renin-angiotensin system in human type 2 diabetic nephropathy
###end article-title 116
###begin article-title 117
Structure-based identification of small-molecule angiotensin-converting enzyme 2 activators as novel antihypertensive agents
###end article-title 117

